Drug Database
Back to search

Poland· PL-100298829

Elin

A norgestimate and ethinylestradiol product containing norgestimatum + ethinylestradiolum, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A.. The same ATC class is registered in 7 of our 19 countries.

ATC G03AA11

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedElinATCG03AA11REGISTER NO.PL-100298829PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about norgestimatum + ethinylestradiolumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Norgestimate and ethinylestradiol is registered in 7 of 19 countries.

Countries holding a registration under ATC G03AA11 (norgestimate and ethinylestradiol), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose
Search norgestimate and ethinylestradiol products by name

Norgestimate and ethinylestradiol · ATC G03AA11

7 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Norgestimatum + Ethinylestradiolum
Manufacturer
Zakłady Farmaceutyczne POLPHARMA S.A.
Country
Poland (PL)
ATC code
G03AA11
ATC class
Norgestimate and ethinylestradiol
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909991064105
  • gtin
    05909991064129
  • gtin
    05909991064136
  • gtin
    05909991064143

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

31 interactions on record for norgestimate and ethinylestradiol.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check norgestimate and ethinylestradiol against other medicinesHow interaction checks work

Norgestimate and ethinylestradiol · interactions on record

31 records

31 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Norgestimate and ethinylestradiol in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All norgestimate and ethinylestradiol products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Belgium · Cibel
  • Germany · Amicette, Lysandra
  • Denmark · Amorina, Liberelle
  • Spain · Edelsine
  • France · Femi, Naravela
  • United Kingdom (Northern Ireland) · Cilique, Lizinna
  • Ireland · Cilique
  • Italy · Briladona, Briladona Trifase
  • Netherlands · Norgestimaat/Ethinylestradiol Xiromed
  • Norway · Amorina
  • Portugal · Etinilestradiol + Norgestimato Leon Farma, Femi
  • Sweden · Amorina

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/81e4f2b3-6b37-44d9-a9fe-5a1997afb0ef
GET /v1/drugs/81e4f2b3-6b37-44d9-a9fe-5a1997afb0ef?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "250 mcg + 35 mcg",
  "packaging": "05909991064105 ¦ Rp ¦ 84431\n21 tabl.\n05909991064129 ¦ Rp ¦ 84432\n63 tabl.\n05909991064136 ¦ Rp ¦ 84433\n126 tabl.\n05909991064143 ¦ Rp ¦ 84434\n273 tabl.",
  "substance": "Norgestimatum 250 mcg + Ethinylestradiolum 35 mcg",
  "common_name": "Norgestimatum + Ethinylestradiolum",
  "pl_product_id": "100298829",
  "pozwolenie_nr": "21205",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about norgestimate and ethinylestradiol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console